These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6271784)

  • 41. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The specificity of two proteinases that cleave adjacent to arginine, C1 esterase and acrosin, for peptide p-nitroanilide substrates.
    Skoog MT; Mehdi S; Wiseman JS; Bey P
    Biochim Biophys Acta; 1989 Jun; 996(1-2):89-94. PubMed ID: 2500154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Component deficiencies. 1. The first component: C1q, C1r, C1s.
    Loos M; Heinz HP
    Prog Allergy; 1986; 39():212-31. PubMed ID: 3031693
    [No Abstract]   [Full Text] [Related]  

  • 44. Quantitation of proenzyme C1r-C1s complexes in serum by electroimmunoassay.
    Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Dec; 89(6):391-2. PubMed ID: 6278826
    [No Abstract]   [Full Text] [Related]  

  • 45. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C1 activation and dissociation in disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proenzymic C1s associated with catalytic amounts of C1r. Study of the activation process.
    Arlaud GJ; Reboul A; Colomb MG
    Biochim Biophys Acta; 1977 Nov; 485(1):227-35. PubMed ID: 303116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic studies of low-abundance human plasma proteins. XI. Linkage analysis and population genetics of the C1S subcomponent of the first complement component.
    Lyons LA; Kamboh MI; Ferrell RE
    Complement Inflamm; 1989; 6(2):81-7. PubMed ID: 2541966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization.
    Rossi V; Bally I; Lacroix M; Arlaud GJ; Thielens NM
    Methods Mol Biol; 2014; 1100():43-60. PubMed ID: 24218249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical characterization and location of ionic interactions involved in the assembly of the C1 complex of human complement.
    Illy C; Thielens NM; Arlaud GJ
    J Protein Chem; 1993 Dec; 12(6):771-81. PubMed ID: 8136028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.
    Cooper NR; Ziccardi RJ
    J Immunol; 1977 Nov; 119(5):1664-7. PubMed ID: 915274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A molecular dynamics study of C1r and C1s dimers: implications for the structure of the C1 complex.
    Beveridge AJ; Wallis R; Samani NJ
    Proteins; 2012 Aug; 80(8):1987-97. PubMed ID: 22488778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural changes in C4 produced by cleavage with C1-s.
    Reboul A; Thielens N; Villiers MB; Colomb MG
    FEBS Lett; 1980 Jun; 115(1):118-22. PubMed ID: 6967020
    [No Abstract]   [Full Text] [Related]  

  • 55. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The N-terminal CUB-epidermal growth factor module pair of human complement protease C1r binds Ca2+ with high affinity and mediates Ca2+-dependent interaction with C1s.
    Thielens NM; Enrie K; Lacroix M; Jaquinod M; Hernandez JF; Esser AF; Arlaud GJ
    J Biol Chem; 1999 Apr; 274(14):9149-59. PubMed ID: 10092586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
    Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
    Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetics of activation of the first component of complement (C1) by IgG oligomers.
    Tschopp J
    Mol Immunol; 1982 May; 19(5):651-7. PubMed ID: 6287242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C1r serine proteinase of human complement: a case of intramolecular autolytic activation.
    Arlaud GJ; Colomb MG; Villiers CL
    Biosci Rep; 1985; 5(10-11):831-7. PubMed ID: 3006820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
    O'Brien G; Quinsey NS; Whisstock JC; Pike RN
    Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.